Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1024478 | 0.83 | MAPT (0.59) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL29074082 | 0.83 | ESR1 (0.50) | KMT2AALDH1A1TSHRESR1ESR2 | |
| SCHEMBL1492728 | 0.83 | CYP2C19 (0.50) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL27759681 | 0.82 | CES1 (0.50) | CYP2C19HIF1AMAPTKMT2AHDAC3 | |
| SCHEMBL15109990 | 0.82 | MEN1 (0.43) | MAPTKMT2AKCNN4KIF11MAPK1 | |
| SCHEMBL27825524 | 0.82 | OPRM1 (0.49) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL7097465 | 0.82 | MIF (0.48) | CYP2C19MAPTKMT2ACYP1A2CYP2D6 | |
| SCHEMBL20176120 | 0.82 | HIF1A (0.46) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL23453194 | 0.81 | TAAR1 (0.54) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL3719792 | 0.81 | CYP2C19 (0.64) | CYP2C19HIF1AMAPTKMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11315064-A | — | — | None | — | — | JP | disclosed |
| WO-2025072539-A1 | AMINO ACID COMPOUNDS WITH NITROGEN LINKERS AND USES THEREOF | PLIANT THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-2022242779-A1 | BIOMARKER COMBINATION FOR ASSESSING RISK OF ADENOMA AND COLORECTAL CANCER, AND USE THEREOF | 深圳市绘云生物科技有限公司 | 2022-11-24 | — | — | WO | disclosed |
| US-10144004-B2 | Method for producing catalyst composition for hydrogenation and catalyst composition for hydrogenation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-12-04 | — | — | US | disclosed |
| US-10016749-B2 | Catalyst composition for hydrogenation and method for hydrogenation using the same | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| EP-2898949-B1 | HYDROGENATION CATALYST COMPOSITION AND HYDROGENATION METHOD USING SAID HYDROGENATION CATALYST COMPOSITION | ASAHI CHEMICAL IND (JP) | 2018-04-04 | — | — | EP | disclosed |
| EP-2898950-B1 | CATALYST COMPOSITION FOR HYDROGENATION AND HYDROGENATION METHOD USING CATALYST COMPOSITION FOR HYDROGENATION | ASAHI CHEMICAL IND (JP) | 2017-11-08 | — | — | EP | disclosed |
| EP-2913348-B1 | METHOD OF PRODUCING HYDROGENATION CATALYST COMPOSITION AND HYDROGENATION CATALYST COMPOSITION | ASAHI CHEMICAL IND (JP) | 2017-09-20 | — | — | EP | disclosed |
| US-9522393-B2 | Catalyst composition for hydrogenation and method for hydrogenation using the same | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-12-20 | — | — | US | disclosed |
| US-20150298112-A1 | METHOD FOR PRODUCING CATALYST COMPOSITION FOR HYDROGENATION AND CATALYST COMPOSITION FOR HYDROGENATION | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-10-22 | — | — | US | disclosed |
| CN-1827598-A | Substituted benzyl ester and its preparation process and novel process for preparing substituted mopipe therefrom | TIANJIN TAIPU PHARMACEUTICAL S (CN) | 2006-09-06 | — | — | CN | disclosed |
| US-6720079-B2 | THERMOSETTING POWDER COMPOSITION INCLUDING EPOXIDE CROSSLINKER AND POLYESTER HAVING TERMINAL TERTIARY CARBOXYL GROUPS FORMED BY REACTING PREPOLYESTER WITH COMPOUND HAVING TERTIARY CARBOXYL GROUP AND ANOTHER CARBOXYL GROUP OR HYDROXYL GROUP | UCB, S.A. (BE) | 2004-04-13 | — | — | US | disclosed |
| US-20030148130-A1 | Surface appearance, good flexibility and good resistance to poor weather conditions. | MOENS LUC (BE) | 2003-08-07 | — | — | US | disclosed |
| US-6461742-B1 | THERMOSETTING POWDER COMPOSITION, COMPRISING BETA-HYDROXYALKYLAMIDE CROSSLINKING AGENT AND POLYESTER HAVING TERMINAL TERTIARY CARBOXYL GROUPS, HAVING SPECIFIED ACID NUMBER | UCB, S.A. (BE) | 2002-10-08 | — | — | US | disclosed |
| CN-1293686-A | Polyester containing tertiary carboxyl groups, preparation method and thermosetting powder compositions containing same | UCB SA (BE) | 2001-05-02 | — | — | CN | disclosed |
| EP-1091938-A2 | ANTIHISTAMINIC PIPERIDINE DERIVATIVES AND INTERMEDIATES FOR THE PREPARATION THEREOF | Aventis Pharmaceuticals Inc. (US) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001671-A2 | ANTIHISTAMINIC PIPERIDINE DERIVATIVES AND INTERMEDIATES FOR THE PREPARATION THEREOF | AVENTIS PHARMACEUTICALS INC. (US) | 2000-01-13 | — | — | WO | disclosed |
| JP-H11315064-A | PRODUCTION OF OPTICALLY ACTIVE PHENYLPROPIONIC ACID DERIVATIVE | AJINOMOTO CO INC | 1999-11-16 | — | — | JP | disclosed |
| EP-0705245-A1 | NOVEL INTERMEDIATES FOR THE PREPARATION OF ANTIHISTAMINIC 4-DIPHENYLMETHYL/DIPHENYLMETHOXY PIPERIDINE DERIVATIVES | MERRELL PHARMACEUTICALS INC. (US) | 1996-04-10 | — | — | EP | disclosed |
| WO-1995000480-A1 | NOVEL INTERMEDIATES FOR THE PREPARATION OF ANTIHISTAMINIC 4-DIPHENYLMETHYL/DIPHENYLMETHOXY PIPERIDINE DERIVATIVES | MERRELL PHARMACEUTICALS INC. (US) | 1995-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10016749-B2 | Catalyst composition for hydrogenation and method for hydrogenation using the same | H1-0, H1-2, HVCN1 | CYP2C19 2138/4885HIF1A 501/4885MAPT 4561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.